Cargando…

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults

OBJECTIVE: To determine cross-sectional adherence with the multi-target stool DNA test used for colorectal cancer screening in a large, fully insured Medicare population. METHODS: All patients aged 65–85 with a valid multi-target stool DNA test order from 1 September 2016 to 31 August 2017 identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiser, Emily, Parks, Philip D, Swartz, Rebecca K, Thomme, Jack Van, Lavin, Philip T, Limburg, Paul, Berger, Barry M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905742/ https://www.ncbi.nlm.nih.gov/pubmed/32054393 http://dx.doi.org/10.1177/0969141320903756

Ejemplares similares

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Barriers to utilization of three colorectal cancer screening options – Data from a national survey
por: Zhu, Xuan, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Lowering Colorectal Cancer Screening Initiation Age to 45 Years: Results From a Survey of Clinicians in the U.S.
por: Rutten, Lila J. Finney, et al.
Publicado: (2020)

An examination of socioeconomic and racial/ethnic disparities in the awareness, knowledge and utilization of three colorectal cancer screening modalities
por: Zhu, Xuan, et al.
Publicado: (2021)

Provider-perceived barriers to patient adherence to colorectal cancer screening
por: Zhu, Xuan, et al.
Publicado: (2021)

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model
por: Piscitello, Andrew, et al.
Publicado: (2020)

Colorectal cancer screening completion: An examination of differences by screening modality
por: Finney Rutten, Lila J., et al.
Publicado: (2020)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
por: Zhu, Yunfeng, et al.
Publicado: (2022)

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study
por: Itzkowitz, Steven, et al.
Publicado: (2023)

Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients
por: Prince, Mark, et al.
Publicado: (2017)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population
por: Hathway, Joanne M, et al.
Publicado: (2021)

Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy
por: Eckmann, Jason D., et al.
Publicado: (2020)

Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA
por: Ebner, Derek W., et al.
Publicado: (2021)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results
por: Chen, Lihong, et al.
Publicado: (2019)

Real-World Management of High Stool Output in Patients with Short Bowel Syndrome: An International Multicenter Survey
por: Lakananurak, Narisorn, et al.
Publicado: (2023)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
por: Zhu, Xuan, et al.
Publicado: (2022)

Adherence to omalizumab: A multicenter "real-world" study
por: Campisi, Raffaele, et al.
Publicado: (2020)

Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy
por: Tsioufis, Konstantinos, et al.
Publicado: (2021)

Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)
por: Heigh, Russell I., et al.
Publicado: (2014)

Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
por: Pericay, Carles, et al.
Publicado: (2023)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

The Effects of a Digital Well-being Intervention on Older Adults: Retrospective Analysis of Real-world User Data
por: Boucher, Eliane, et al.
Publicado: (2022)

Real-world adherence to topical therapies in patients with moderate acne
por: Lam Hoai, Xuân-Lan, et al.
Publicado: (2021)

Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities
por: Bailey, James R., et al.
Publicado: (2016)

DNA methylation biomarkers in stool for early screening of colorectal cancer
por: Chen, Jie, et al.
Publicado: (2019)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Real Time Versus Photographic Assessment of Stool Consistency Using the Brussels Infant and Toddler Stool Scale: Are They Telling Us the Same?
por: Aman, Berthold Albert, et al.
Publicado: (2021)

Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tt5b4g6kikqi5h2ocmsi7gnssu